Faculty Opinions recommendation of Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.

2018 ◽  
Author(s):  
Richard Riedel
Keyword(s):  
Anaplastic Lymphoma Kinase ◽  
Phase 2 ◽  
Kinase Gene ◽  
European Organisation ◽  
Anaplastic Lymphoma ◽  
Single Drug ◽  
Phase 2 Trial ◽  
Anaplastic Lymphoma Kinase Gene ◽  
Gene Alterations

scholarly journals Anaplastic Lymphoma Kinase Gene Analysis as a Useful Tool for Identifying Primary Unknown Metastatic Lung Adenocarcinoma

2014 ◽  
Vol 53 (23) ◽  
pp. 2711-2715 ◽  
Author(s):  
Naoki Watanabe ◽  
Tomoya Ishii ◽  
Takayuki Takahama ◽  
Akira Tadokoro ◽  
Nobuhiro Kanaji ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Anaplastic Lymphoma Kinase ◽  
Gene Analysis ◽  
Kinase Gene ◽  
Anaplastic Lymphoma ◽  
Metastatic Lung ◽  
Anaplastic Lymphoma Kinase Gene

scholarly journals Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers

2020 ◽  
Vol Volume 13 ◽  
pp. 6927-6935
Author(s):  
De-Ning Ma ◽  
Xin-Yi Gao ◽  
Yi-Bo Dan ◽  
An-Ni Zhang ◽  
Wei-Jun Wang ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Anaplastic Lymphoma Kinase ◽  
Gene Rearrangement ◽  
Kinase Gene ◽  
Anaplastic Lymphoma ◽  
Anaplastic Lymphoma Kinase Gene
Sign in / Sign up

Export Citation Format

Share Document